VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV
· Real-Time Price · USD
0.07
-0.06 (-47.33%)
At close: Aug 07, 2024, 8:00 PM
-47.33% (1D)
| Bid | n/a |
| Market Cap | 1.87M |
| Revenue (ttm) | 9.41M |
| Net Income (ttm) | -82.98M |
| EPS (ttm) | -3.54 |
| PE Ratio (ttm) | -0.01844632768361582 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 27,931,464 |
| Avg. Volume (20D) | 8,393,583 |
| Open | 0.09 |
| Previous Close | 0.13 |
| Day's Range | 0.06 - 0.09 |
| 52-Week Range | 0.06 - 1.35 |
| Beta | 2.17 |
About VBIV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VBIV
Website n/a
9 months ago
VBI Vaccines shares are trading higher on volatili...
Unlock content with
Pro Subscription
9 months ago
VBI Vaccines shares are trading lower after the company was granted protection under Canada's CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst & Young was appointed as the monitor during the restructuring process.